Brown Brothers Harriman & Co’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-55,000
Closed -$384K 1871
2025
Q4
$384K Hold
55,000
﹤0.01% 601
2025
Q3
$314K Sell
55,000
-4,500
-8% -$24K ﹤0.01% 592
2025
Q2
$284K Buy
59,500
+35,800
+151% +$205K ﹤0.01% 562
2025
Q1
$205K Buy
23,700
+13,285
+128% +$139K ﹤0.01% 554
2024
Q4
$126K Buy
10,415
+10,209
+4,956% +$143K ﹤0.01% 675
2024
Q3
$3.46K Buy
+206
New +$3.39K ﹤0.01% 1217
2020
Q2
Sell
-254
Closed -$9K 1118
2020
Q1
$9K Buy
+254
New +$8.34K ﹤0.01% 707
2018
Q1
Sell
-53
Closed -$2K 1016
2017
Q4
$2K Buy
+53
New +$1.61K ﹤0.01% 1048

Other funds holding NEOG

Brown Brothers Harriman & Co's NEOG Position: Q1 2026 in Review

Brown Brothers Harriman & Co sold out of Neogen (NEOG) in Q1 2026, closing a stake of 55,000 shares — an estimated $384K sold.

Brown Brothers Harriman & Co first reported a position in NEOG in Q4 2017 and held it in 8 quarters. The position peaked at $384K in Q4 2025. 307 funds tracked by Wall St. Rank hold NEOG as of Q1 2026.

  • Brown Brothers Harriman & Co reported no remaining Neogen position as of Q1 2026 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 55,000 Neogen shares in Q1 2026, an estimated $384K.
  • Brown Brothers Harriman & Co first reported a position in Neogen in Q4 2017 and held it in 8 quarters.
  • Brown Brothers Harriman & Co's Neogen position peaked at $384K in Q4 2025.
  • 307 funds tracked by Wall St. Rank held Neogen as of Q1 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.